Press Releases

Curaleaf Celebrates Miami North Biscayne Dispensary Opening

New North Miami Beach location expands the Company's retail presence to 62 locations in Florida and 146 nationwide

NEW YORK, May 22, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of Curaleaf Miami North Biscayne, located at 2250 NE 163rd St. Suite 1, North Miami Beach, FL 33160. The location marks the Company's 62nd dispensary in Florida and 146th nationwide.

Conveniently situated near Florida's largest urban park, Oleta River State Park, and North Miami Beach, Curaleaf's newest retail location opened its doors to licensed medical patients on May 21. The dispensary will operate from 9:00 a.m. to 8:30 p.m. ET Monday through Saturday and 10:00 a.m. to 7:00 p.m. ET on Sunday. Curaleaf Miami North Biscayne will celebrate its grand opening on June 1 with a ribbon-cutting ceremony at 9:00 a.m. ET, followed by festivities throughout the day, including exclusive doorbuster deals and giveaways.

"With a presence now in South and North Miami Beach, we are thrilled to be expanding our ability to serve the growing community of patients in this vibrant area," said Matt Darin, CEO of Curaleaf. "Our newest dispensary in the Sunshine State is our seventh store in the Miami area. We'll offer a diverse range of top-quality products and brands, in addition to the educational resources and exceptional service our patients have come to trust. Momentum for cannabis in Florida is at an all-time high, with Measure 3 on the ballot this Fall, and strong bipartisan support for adult-use cannabis across the state. We're proud to support #YesOn3!"

Curaleaf Miami North Biscayne will feature the Company's premium suite of products, including Grassroots craft flower and pre-rolls, Select Briq all-in-one vape and Liquid Diamonds. Pending regulatory approval, the Company also expects to debut a range of new products in the coming months, across categories including tinctures, edibles and more.

Patients can access products conveniently through delivery while earning loyalty points for every dollar spent through the Company's refreshed loyalty program. Loyalty points earned can be redeemed for savings on future purchases made at Curaleaf Miami North Biscayne or any other Curaleaf-operated dispensary. Patients can monitor their rewards program progress, order their favorite products, and receive exclusive updates on new products and discounts all through Curaleaf's mobile app.

For more information on Curaleaf's locations, patient resources, and products in Florida, please visit

About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit

Forward Looking Statements:

This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of the new Miami North Biscayne dispensary. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 6, 2024, which is available under the Company's SEDAR profile at, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.


Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer

Media Contact: 
Curaleaf Holdings, Inc.
Tracy Brady, SVP Corporate Communications

SOURCE Curaleaf Holdings, Inc.